share_log

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm 已收到一項授予歐洲專利號 EP3283620 的決定,該專利號爲 “改性伽瑪三角洲細胞及其用途(用於治療人類癌症或傳染病)”
Benzinga ·  03/21 15:32

EP About this file - European Patent Register (epo.org)

EP 關於此文件-歐洲專利註冊局 (epo.org)

Image
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論